No compound A formation with Superia® during minimal-flow sevoflurane anesthesia: A comparison with Sofnolime®

Anesthesia and Analgesia

Volumn 95, Issue 6, 2002, Pages 1680-1685

  Bouche, Marie Paule L A ^a   Versichelen, Linda F M ^b   Struys, Michel M R F ^b   Van Bocxlaer, Jan F P ^a   De Leenheer, André P ^a   Mortier, Eric P ^b   Rolly, Georges ^b  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBENT; CARBON DIOXIDE; DRUG METABOLITE; OXYGEN; POTASSIUM HYDROXIDE; PROPOFOL; REMIFENTANIL; SEVOFLURANE; SODIUM HYDROXIDE;

ADULT; AIR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRIEDMAN TEST; GENERAL ANESTHESIA; HUMAN; MALE; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL ANALYSIS; TEMPERATURE DEPENDENCE; VENTILATOR;

EID: 0036896802     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200212000-00039     Document Type: Article

References (21)

1. Kandel L, Laster MJ, Eger EI II, et al. Nephrotoxicity in rats undergoing a one-hour exposure to compound A. Anesth Analg 1995;81:559-63.
2. Ebert TJ, Messana LD, Uhrich TD, Staacke TS. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers. Anesth Analg 1998;86:662-7.
3. Karash ED, Frink EJ Jr, Zager R, et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997;86: 1238-53.
4. Mazze RI, Jamison RL. Low-flow (1 1/min) sevoflurane: Is it safe? Anesthesiology 1997;86:1225-7.
5. Neumann MA, Laster MJ, Weiskopf RB, et al. The elimination of sodium and potassium hydroxides from desiccated soda lime diminishes degradation of desflurane to carbon monoxide and sevoflurane to compound A but does not compromise carbon dioxide absorption. Anesth Analg 1999;89:768-73.
6. Stabernack CR, Brown R, Laster MJ, et al. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Anesth Analg 2000;90:1428-35.
7. 2 absorbent in a standard anesthetic circuit. J Anesth 2000;14:143-6.
8. Murray JM, Renfrew CW, Bedi A, et al. Amsorb: A new carbon dioxide absorbent for use in anesthetic breathing systems. Anesthesiology 1999;91:1342-8.
9. Versichelen LFM, Bouche MPLA, Rolly G, et al. Only carbon dioxide absorbents free of both NaOH and KOH prevent formation of compound A during in vitro closed-system sevoflurane: Evaluation of five absorbents. Anesthesiology 2001;95:750-5.
10. 2 absorbent (Amsorb). In: Book of Abstracts, 12th World Congress of Anaesthesiology, Montreal, Canada, 2000. 4.4.21.
11. Kharash ED. Putting the brakes on anesthetic breakdown. Anesthesiology 1999;91:1192-4.
12. Goeters C, Reinhardt C, Gronau E, et al. Minimal flow sevoflurane and isoflurane anaesthesia and impact on renal function. Eur J Anaesthesiol 2001;18:43-50.
13. Versichelen L, Bouche MP, Struys M, et al. Compound A production from sevoflurane is not less when KOH-free absorbent is used in a closed-circuit lung model system. Br J Anaesth 2001;86:345-8.
14. Yamakage M, Kimura A, Chen X, et al. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine. Can J Anaesth 2001;48:435-8.
15. Munday IT, Ward PM, Foden ND, et al. Sevoflurane degradation by soda lime in a circle breathing system. Anaesthesia 1996;51:622-6.
16. Liu J, Laster MJ, Eger EI II, Tahari S. Absorption and degradation of sevoflurane and isoflurane in a conventional anesthetic circuit. Anesth Analg 1991;72:785-9.
17. 2 absorbants during low-flow anesthesia in surgical patients. Anesthesiology 1992;77:1064-9.
18. Bito H, Ikeda K. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Anesthesiology 1994;81:340-5.
19. Eger IE. Compound A: Does it matter? Can J Anaesth 2001;48:427-30.
20. Hendrickx JFA, De Cooman S, Deloof T, et al. The ADU vaporizing unit: A new vaporizer. Anesth Analg 2001;93:391-5.
21. Bouche MPLA, Van Bocxlaer JFP, Rolly G, et al. Quantitative determination of vapor phase compound A in sevoflurane anesthesia using gas chromatography-mass spectrometry. Clin Chem 2001;47:281-91.